EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 22 filers reported holding EVOGENE LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $116,000 | -89.8% | 63,522 | -88.9% | 0.00% | – |
| Q4 2018 | $1,132,000 | -29.2% | 571,940 | +11.3% | 0.00% | – |
| Q3 2018 | $1,599,000 | +20.7% | 514,089 | +11.0% | 0.00% | – |
| Q2 2018 | $1,325,000 | -9.9% | 463,266 | 0.0% | 0.00% | – |
| Q1 2018 | $1,471,000 | -8.9% | 463,266 | +6.2% | 0.00% | – |
| Q4 2017 | $1,614,000 | -16.6% | 436,082 | 0.0% | 0.00% | – |
| Q3 2017 | $1,936,000 | -20.8% | 436,082 | -0.0% | 0.00% | – |
| Q2 2017 | $2,443,000 | +9.1% | 436,225 | +4.2% | 0.00% | – |
| Q1 2017 | $2,240,000 | +9.3% | 418,834 | +4.2% | 0.00% | – |
| Q4 2016 | $2,050,000 | -20.0% | 401,870 | 0.0% | 0.00% | – |
| Q3 2016 | $2,564,000 | +7.5% | 401,870 | +5.2% | 0.00% | – |
| Q2 2016 | $2,385,000 | +10.3% | 382,146 | +15.0% | 0.00% | – |
| Q1 2016 | $2,163,000 | -8.0% | 332,205 | +13.8% | 0.00% | – |
| Q4 2015 | $2,351,000 | -45.0% | 292,030 | -43.6% | 0.00% | – |
| Q3 2015 | $4,274,000 | +97.0% | 518,162 | +111.1% | 0.00% | – |
| Q2 2015 | $2,170,000 | +21.3% | 245,479 | +21.0% | 0.00% | – |
| Q1 2015 | $1,789,000 | – | 202,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,100,000 | $1,818,150 | 0.55% |
| CVI Holdings, LLC | 261,636 | $153,214 | 0.30% |
| Malaga Cove Capital, LLC | 12,000 | $7,038 | 0.00% |
| Csenge Advisory Group | 30,762 | $18,042 | 0.00% |
| Joel Isaacson & Co., LLC | 30,300 | $17,771 | 0.00% |
| Walleye Capital LLC | 517,092 | $302,809 | 0.00% |
| Virtu Financial LLC | 11,605 | $7 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $5,865 | 0.00% |
| Sigma Planning Corp | 50,985 | $29,903 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,692 | $8,617 | 0.00% |